WeVote
Log In

Bill

Bill

HB 561

RELATING TO PHARMACISTS.

2025 Regular Session Introduced by Cory Chun and 11 co-sponsors

Hawaii bill addressing pharmacist regulations and professional scope, referred to health and consumer protection committees for consideration in 2026 session.

Carried over to 2026 Regular Session.
#medicallyunderservedpatients #pharmacists #telepharmacy
0
WeVote Research Nonpartisan
Bill Summary · HB 561

Legislative bill overview

HB 561 relates to pharmacist regulations and scope of practice in Hawaii, though the specific provisions are not detailed in the available legislative summary. The bill was introduced in January 2025 and carried over to the 2026 Regular Session after being referred to the Health (HLT) and Consumer Protection & Commerce (CPC) committees.

Why is this important

Pharmacist scope-of-practice legislation affects healthcare accessibility and cost, as expanded pharmacist authority can allow patients to access services without physician visits, while restrictions protect medical oversight. Hawaii's healthcare system serves island communities where pharmacist availability may significantly impact patient care options and medication management services.

Potential points of contention

  • Scope expansion vs. physician oversight: Questions about whether pharmacists should independently prescribe, administer vaccines, or manage chronic conditions versus requiring physician collaboration
  • Licensure and credentialing standards: Debates over educational requirements, certifications, and training needed for expanded duties
  • Insurance and liability implications: Uncertainty over who bears responsibility for medication errors or adverse outcomes when pharmacists operate independently

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.